Not a traditional drug phase: testing Lidocaine IV for Chronic Pain Syndrome
The purpose of this research is to gather data on the performance and functionality of IV lidocaine infusions prescribed to patients with chronic pain.
Official registry: https://clinicaltrials.gov/study/NCT07929636 · International Spine, Pain and Performance Center · enrollment listed as 100
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 100 people at Washington D.C.. Taking part typically means taking a study drug (or dummy pill) plus check-ins.
Official title (unrewritten)
Tracking Outcomes by Secondary Diagnoses in Patients Prescribed Intravenous Lidocaine for Chronic Pain
Interventions: Lidocaine IV
Primary outcome (registry wording): Change from Baseline in Pain Intensity on the Visual Analog Scale (VAS) at 3 Months
Who it is for (from inclusion criteria)
- Ages 18 Years to 80 Years
- Patients with chronic pain syndrome
- Patients that have been prescribed and scheduled to receive an intravenous lidocaine infusion treatment
Who the registry excludes
- People the protocol lists as excluded — the study team must confirm.
Public study contact (from the registry)
Victoria Brownlee, MPH
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
1 listed- International Spine Pain & Performance Center — Washington D.C., District of Columbia (recruiting)
FAQ about this NCT record
Is NCT07929636 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT07929636?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT07929636?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary